Dapaglyn M 500 mg tablet is a combination of two anti diabetic medications used to treat type 2 diabetes mellitus Each film coated Dapaglyn M 500 mg tablet contains Dapagliflozin Propanedion monohydrate eq to Dapagliflozin 10 mg Metformin Hydrochloride 500 mg In extended release form Dapagliflozin is a sodium glucose co transporter 2 SGLT2 inhibitor inhibits the SGLT2 co transporter which leads to lower reabsorption of filtered glucose into the body and decreases the renal threshold for glucose RTG leading to increased glucose excretion in the urine Metformin is a biguanide antihyperglycaemic agent which improves glucose tolerance by lowering both basal and postprandial plasma glucose It decreases hepatic glucose production delays intestinal glucose absorption and improves insulin sensitivity by enhancing peripheral glucose uptake and utilization

Inform your doctor if you take other antidiabetic drugs so that the dosage of DAPAGLYN M 500 TABLETS 15 S will be adjusted accordingly Do not abruptly stop taking DAPAGLYN M 500 TABLETS 15 S midway if the doctor did not advise you DAPAGLYN M 500 TABLETS 15 S may cause hypoglycaemia low blood sugar hence it is advised to make healthy food with enough calories and avoid heavy exercises Brief your medical history to doctor if you have any heart kidney or liver diseases breathing problems asthma obstructive lung diseases blood problems like anaemia lack of blood cells vitamin B12 deficiency pancreas problems surgery dehydration alcohol use low blood pressure and yeast infection of genitals before taking DAPAGLYN M 500 TABLETS 15 S Avoid alcohol intake while using DAPAGLYN M 500 TABLETS 15 S since it may increase the risk of lactic acidosis DAPAGLYN M 500 TABLETS 15 S is not recommended for use during the second or third trimester of pregnancy and breastfeeding Your doctor may advise alternate medications to control your diabetic condition in such cases DAPAGLYN M 500 TABLETS 15 S is not recommended for people younger than 18 years of age